Disclosure Of Entity's Operating Segments [Text Block]

Transgene - Filing #833175

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Disclosure of entity's operating segments [text block]
NOTE
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Tax expense (income)
- EUR
EUR
Profit (loss) before tax
22 328 EUR
32 804 EUR
Profit (loss)
- EUR
22 328 EUR
22 328 EUR
- EUR
- EUR
22 328 EUR
- EUR
- EUR
- EUR
- EUR
- EUR
32 804 EUR
32 804 EUR
- EUR
32 804 EUR
- EUR
Assets
45 217 EUR
66 436 EUR
Liabilities
29 605 EUR
28 595 EUR
Cash flows from (used in) operating activities
34 671 EUR
20 303 EUR
Cash flows from (used in) investing activities
34 572 EUR
20 272 EUR
Cash flows from (used in) financing activities
11 369 EUR
1 477 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.